-
Mashup Score: 2
Anti-GPRC5D CAR T-cell salvage therapy induced a high response rate, and could be a potential treatment option in relapsed or refractory multiple myeloma patients who have progressed after anti-BCMA CAR T-cell treatment. Further investigations are warranted to establish the long-term efficacy and safety of this therapeutic approach.
Source: www.thelancet.comCategories: General Medicine NewsTweet
-
Mashup Score: 13A German multicenter real‐world analysis of talquetamab in 138 patients with relapsed/refractory multiple myeloma - 6 day(s) ago
Bispecific T‐cell engagers (BTCEs) represent a paradigm shift in the treatment of relapsed/refractory multiple myeloma (RRMM). Talquetamab, a GPRC5DxCD3 BTCE, has shown promising results in the MonumenTAL‐1 trial and was recently approved by the …
Source: pmc.ncbi.nlm.nih.govCategories: General Medicine NewsTweet-
https://t.co/U3cjzdom5z #mmsm #myeloma #USMIRC @USMIRCNEWS @OncoAlert #MedTwitter #MedEd #سرطان_الدم #المايلوما
-
-
Mashup Score: 13A German multicenter real‐world analysis of talquetamab in 138 patients with relapsed/refractory multiple myeloma - 6 day(s) ago
Bispecific T‐cell engagers (BTCEs) represent a paradigm shift in the treatment of relapsed/refractory multiple myeloma (RRMM). Talquetamab, a GPRC5DxCD3 BTCE, has shown promising results in the MonumenTAL‐1 trial and was recently approved by the …
Source: pmc.ncbi.nlm.nih.govCategories: General Medicine NewsTweet-
https://t.co/U3cjzdom5z #mmsm #myeloma #USMIRC @USMIRCNEWS @OncoAlert #MedTwitter #MedEd #سرطان_الدم #المايلوما
-
-
Mashup Score: 4
Assessing the Economic impact of elranatamab for treatment of patients with relapsed or (RRMM) refractory multiple myeloma in the USA
Source: www.dovepress.comCategories: General Medicine NewsTweet-
https://t.co/UkxmWEZvHE #mmsm #MedTwitter #MedEd #USMIRC @USMIRCNEWS @OncoAlert #سرطان_الدم #المايلوما
-
-
Mashup Score: 14FLASCO / ICE-T (Immune Cell Effector Therapy) Conference - 10 day(s) ago
Start: 26 July 2025 End: 26 July 2025 Venue: Signia by Hilton Bonnet Creek (14100 Bonnet Creek Resort Ln, Orlando, FL 32821) The agenda covers exciting new therapies including bispecific antibodies, CAR-T therapies with a focus on indications, toxicities, and the role of collaboration in managing complex therapies in hematological diseases and other diseases. The event aims to explore the foundational aspects of bispecific therapy, cell, navigating the landscape in hematologic malignancies and beyond,
Source: flasco.orgCategories: General Medicine NewsTweet-
🌴Our main Speakers are ready for the National ICE-T Conference! Set on 7/26/2025 Orlando/Florida @NausheenAhmedMD @AtrashShebli and many others!! Thanks to #FLASCO for collaborating with @KUcancercenter #USMIRC @USMIRCNEWS & #CORTEX For registration: https://t.co/MBh3TUCxvR https://t.co/HXUunzna3v
-
-
Mashup Score: 14FLASCO / ICE-T (Immune Cell Effector Therapy) Conference - 13 day(s) ago
Start: 26 July 2025 End: 26 July 2025 Venue: Signia by Hilton Bonnet Creek (14100 Bonnet Creek Resort Ln, Orlando, FL 32821) The agenda covers exciting new therapies including bispecific antibodies, CAR-T therapies with a focus on indications, toxicities, and the role of collaboration in managing complex therapies in hematological diseases and other diseases. The event aims to explore the foundational aspects of bispecific therapy, cell, navigating the landscape in hematologic malignancies and beyond,
Source: flasco.orgCategories: General Medicine NewsTweet-
🌴Our main Speakers are ready for the National ICE-T Conference! Set on 7/26/2025 Orlando/Florida @NausheenAhmedMD @AtrashShebli and many others!! Thanks to #FLASCO for collaborating with @KUcancercenter #USMIRC @USMIRCNEWS & #CORTEX For registration: https://t.co/MBh3TUCxvR https://t.co/HXUunzna3v
-
-
Mashup Score: 14FLASCO / ICE-T (Immune Cell Effector Therapy) Conference - 14 day(s) ago
Start: 26 July 2025 End: 26 July 2025 Venue: Signia by Hilton Bonnet Creek (14100 Bonnet Creek Resort Ln, Orlando, FL 32821) The agenda covers exciting new therapies including bispecific antibodies, CAR-T therapies with a focus on indications, toxicities, and the role of collaboration in managing complex therapies in hematological diseases and other diseases. The event aims to explore the foundational aspects of bispecific therapy, cell, navigating the landscape in hematologic malignancies and beyond,
Source: flasco.orgCategories: General Medicine NewsTweet-
🌴Our main Speakers are ready for the National ICE-T Conference! Set on 7/26/2025 Orlando/Florida @NausheenAhmedMD @AtrashShebli and many others!! Thanks to #FLASCO for collaborating with @KUcancercenter #USMIRC @USMIRCNEWS & #CORTEX For registration: https://t.co/MBh3TUCxvR https://t.co/HXUunzna3v
-
-
Mashup Score: 14FLASCO / ICE-T (Immune Cell Effector Therapy) Conference - 15 day(s) ago
Start: 26 July 2025 End: 26 July 2025 Venue: Signia by Hilton Bonnet Creek (14100 Bonnet Creek Resort Ln, Orlando, FL 32821) The agenda covers exciting new therapies including bispecific antibodies, CAR-T therapies with a focus on indications, toxicities, and the role of collaboration in managing complex therapies in hematological diseases and other diseases. The event aims to explore the foundational aspects of bispecific therapy, cell, navigating the landscape in hematologic malignancies and beyond,
Source: flasco.orgCategories: General Medicine NewsTweet-
🌴Our main Speakers are ready for the National ICE-T Conference! Set on 7/26/2025 Orlando/Florida @NausheenAhmedMD @AtrashShebli and many others!! Thanks to #FLASCO for collaborating with @KUcancercenter #USMIRC @USMIRCNEWS & #CORTEX For registration: https://t.co/MBh3TUCxvR https://t.co/HXUunzna3v
-
-
Mashup Score: 4
A large retrospective study investigated respiratory syncytial virus or influenza virus infections in patients with lymphoma and multiple myeloma. Risk fac
Source: academic.oup.comCategories: General Medicine NewsTweet-
https://t.co/my1P4qTdll
-
-
Mashup Score: 0Carfilzomib prescribing patterns and outcomes for relapsed or refractory multiple myeloma: a real-world analysis - 25 day(s) ago
Blood Cancer Journal – Carfilzomib prescribing patterns and outcomes for relapsed or refractory multiple myeloma: a real-world analysis
Source: www.nature.comCategories: General Medicine NewsTweet-
https://t.co/PPx5l7QEFl
-
https://t.co/AIvBqGWUQ4 #mmsm #myeloma #MedEd #MedTwitter #USMIRC @USMIRCNEWS @OncoAlert #سرطان_الدم #المايلوما